Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct location

Stroke

Volumn 43, Issue 8, 2012, Pages 2036-2041

  Jickling, Glen C ^a   Stamova, Boryana ^a   Ander, Bradley P ^a   Zhan, Xinhua ^a   Liu, Dazhi ^a   Sison, Shara Mae ^a   Verro, Piero ^a   Sharp, Frank R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cryptogenic stroke; diagnosis; gene expression; ischemic stroke

Indexed keywords

RNA;

ADULT; ARTERIAL STROKE; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; BRAIN VENTRICLE; CARDIOEMBOLIC STROKE; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE EXPRESSION PROFILING; HEART INFARCTION; HUMAN; HUMAN TISSUE; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROPATHOLOGY; PRIORITY JOURNAL; RNA ISOLATION; STROKE; STROKE PATIENT; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK;

AGED; CEREBRAL ANGIOGRAPHY; CEREBRAL ARTERIAL DISEASES; ELECTROCARDIOGRAPHY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEART DISEASES; HEART FAILURE; HEMODYNAMICS; HUMANS; INFLAMMATION; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; NEUROIMAGING; PROGNOSIS; RISK FACTORS; STROKE; STROKE, LACUNAR; THROMBOEMBOLISM;

EID: 84864289886     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.648725     Document Type: Article

References (26)

1. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
2. Ionita CC, Xavier AR, Kirmani JF, Dash S, Divani AA, Qureshi AI. What proportion of stroke is not explained by classic risk factors? Prev Cardiol. 2005;8:41-46.
3. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to toast criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32: 2735-2740.
4. Jickling GC, Xu H, Stamova B, Ander BP, Zhan X, Tian Y, et al. Signatures of cardioembolic and large-vessel ischemic stroke. Ann Neurol. 2010;68:681-692.
5. Jickling GC, Stamova B, Ander BP, Zhan X, Tian Y, Liu D, et al. Profiles of lacunar and nonlacunar stroke. Ann Neurol. 2011;70:477-485.
6. Pancioli AM, Broderick J, Brott T, Tomsick T, Khoury J, Bean J, et al. The combined approach to lysis utilizing eptifibatide and rtPA in acute ischemic stroke: the CLEAR stroke trial. Stroke. 2008;39: 3268-3276.
7. Jolliffe IT. Principal Component Analysis. New York, NY: Springer; 2002.
8. Stollberger C, Finsterer J. Detection of paroxysmal atrial fibrillation and patent foramen ovale in cryptogenic stroke. Eur J Neurol. 2009;16: 160-161.
9. Elijovich L, Josephson SA, Fung GL, Smith WS. Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors. J Stroke Cerebrovasc Dis. 2009;18:185-189.
10. Amarenco P. Underlying pathology of stroke of unknown cause (cryptogenic stroke). Cerebrovasc Dis. 2009;27(suppl 1):97-103.
11. Tayal AH, Tian M, Kelly KM, Jones SC, Wright DG, Singh D, et al. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology. 2008;71:1696-1701.
12. Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009;40: 2349-2355.
13. Saver JL. Cryptogenic stroke in patients with patent foramen ovale. Curr Atheroscler Rep. 2007;9:319-325.
14. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007;357: 2262-2268.
15. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000;55: 1172-1179.
16. Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke. 1993;24:1865-1873.
17. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, et al. Study design of the CLOSURE I trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the Starflex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Stroke. 2010;41:2872-2883.
18. Harloff A, Dudler P, Frydrychowicz A, Strecker C, Stroh AL, Geibel A, et al. Reliability of aortic MRI at 3 Tesla in patients with acute cryptogenic stroke. J Neurol Neurosurg Psychiatry. 2008;79:540-546.
19. Kitagawa K. Aortogenic embolism is a possible mechanism of cryptogenic stroke. Ann Neurol. 2004;55:598-599.
20. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis. 2009;27:502-508.
21. Ay H, Benner T, Arsava EM, Furie KL, Singhal AB, Jensen MB, et al. A computerized algorithm for etiologic classification of ischemic stroke: the causative classification of stroke system. Stroke. 2007;38: 2979-2984.
22. Homburg PJ, Rozie S, van Gils MJ, van den Bouwhuijsen QJ, Niessen WJ, Dippel DW, et al. Association between carotid artery plaque ulceration and plaque composition evaluated with multidetector ct angiography. Stroke. 2011;42:367-372.
23. Bang OY, Lee PH, Joo SY, Lee JS, Joo IS, Huh K. Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann Neurol. 2003;54:227-234.
24. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke. 2000;31:1062-1068.
25. Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer. N Engl J Med. 2009;360:790-800.
26. Rosenberg S, Elashoff MR, Beineke P, Daniels SE, Wingrove JA, Tingley WG, et al. Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients. Ann Intern Med. 2010;153:425-434.